|
POLR1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.551600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.099500E-02 |
| Normal-vs-Stage2 |
1.608010E-02 |
| Normal-vs-Stage3 |
9.73640000000442E-05 |
| Normal-vs-Stage4 |
3.83860000000569E-05 |
| Stage1-vs-Stage2 |
1.512980E-01 |
| Stage1-vs-Stage3 |
7.239400E-03 |
| Stage1-vs-Stage4 |
2.701300E-03 |
| Stage2-vs-Stage3 |
6.171800E-01 |
| Stage2-vs-Stage4 |
3.362200E-01 |
| Stage3-vs-Stage4 |
5.321400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.008800E-04 |
| Normal-vs-AfricanAmerican |
7.079400E-03 |
| Normal-vs-Asian |
4.689800E-01 |
| Caucasian-vs-AfricanAmerican |
6.789800E-01 |
| Caucasian-vs-Asian |
1.429220E-01 |
| AfricanAmerican-vs-Asian |
8.243700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.66650000000113E-05 |
| Normal-vs-Female |
6.868200E-02 |
| Male-vs-Female |
2.867600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.882100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.818400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.795500E-03 |
| Normal-vs-Age(81-100Yrs) |
7.943100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.003800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.216000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.196200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.389200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.696620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.113150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.088800E-01 |
| Normal-vs-Grade 2 |
1.135420E-01 |
| Normal-vs-Grade 3 |
2.379100E-04 |
| Normal-vs-Grade 4 |
1.94919999996213E-06 |
| Grade 1-vs-Grade 2 |
6.762200E-01 |
| Grade 1-vs-Grade 3 |
1.808360E-01 |
| Grade 1-vs-Grade 4 |
2.900000E-02 |
| Grade 2-vs-Grade 3 |
2.159600E-02 |
| Grade 2-vs-Grade 4 |
3.606400E-04 |
| Grade 3-vs-Grade 4 |
3.013700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.639600E-01 |
| Normal-vs-ccB subtype |
2.74399999999897E-06 |
| ccA subtype-vs-ccB subtype |
2.76930000042697E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.412000E-04 |
| Normal-vs-N1 |
1.991960E-01 |
| N0-vs-N1 |
9.591200E-01 |
|
|
